Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
ESMO Open
|
August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
M H Derbala, J Hajjar, B Stephen, et al.
BMC Cancer
|
October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
X Liu, G C George, A M Tsimberidou, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge
C M Parseghian, J M Loree, V K Morris, et al.
Blood Cancer Journal
|
October 17, 2015
Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
J E Jang, Y H Min, J Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L Liu, J M Toung, A F Jassowicz, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
ESMO Open
|
August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
M H Derbala, J Hajjar, B Stephen, et al.
BMC Cancer
|
October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
X Liu, G C George, A M Tsimberidou, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge
C M Parseghian, J M Loree, V K Morris, et al.
Blood Cancer Journal
|
October 17, 2015
Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
J E Jang, Y H Min, J Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L Liu, J M Toung, A F Jassowicz, et al.
Page
of 5